These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 8672822)
1. Experience in the development of a postmarketing surveillance network: the pharmacy medication monitoring program. Willison DJ; Gaebel KA; Borden EK; Levine MA; Poston JW; Goldsmith CH; Wong B Ann Pharmacother; 1995 Dec; 29(12):1208-13. PubMed ID: 8672822 [TBL] [Abstract][Full Text] [Related]
2. Community pharmacy and pharmacist staff call center: assessment of medication safety and effectiveness. Higgins L; Brown M; Murphy JE; Malone DC; Armstrong EP; Woosley RL J Am Pharm Assoc (2003); 2011; 51(1):82-9. PubMed ID: 21247830 [TBL] [Abstract][Full Text] [Related]
3. Identification and evaluation of a possible signal of exacerbation of colitis during rofecoxib treatment, using Prescription-Event Monitoring data. Layton D; Heeley E; Shakir SA J Clin Pharm Ther; 2004 Apr; 29(2):171-81. PubMed ID: 15068407 [TBL] [Abstract][Full Text] [Related]
4. Postmarketing surveillance of adverse drug reactions: patient self-monitoring. Fisher S; Bryant SG J Am Board Fam Pract; 1992; 5(1):17-25. PubMed ID: 1561919 [TBL] [Abstract][Full Text] [Related]
5. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta. Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085 [TBL] [Abstract][Full Text] [Related]
6. Pain and pain medication use in community-dwelling older adults. Sawyer P; Bodner EV; Ritchie CS; Allman RM Am J Geriatr Pharmacother; 2006 Dec; 4(4):316-24. PubMed ID: 17296537 [TBL] [Abstract][Full Text] [Related]
7. Impact of preexisting health conditions on the outcome of an adverse drug reaction alerting program: gastrointestinal disorders before piroxicam and sulindac therapy. Rawson NS Ann Pharmacother; 1995; 29(7-8):676-80. PubMed ID: 8520079 [TBL] [Abstract][Full Text] [Related]
8. Assessing health literacy practices in a community pharmacy environment: experiences using the AHRQ Pharmacy Health Literacy Assessment Tool. O'Neal KS; Crosby KM; Miller MJ; Murray KA; Condren ME Res Social Adm Pharm; 2013; 9(5):564-96. PubMed ID: 23267822 [TBL] [Abstract][Full Text] [Related]
9. Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK. Layton D; Sinclair HK; Bond CM; Hannaford PC; Shakir SA Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):503-13. PubMed ID: 12426936 [TBL] [Abstract][Full Text] [Related]
10. Exercise-associated hyponatremia, renal function, and nonsteroidal antiinflammatory drug use in an ultraendurance mountain run. Page AJ; Reid SA; Speedy DB; Mulligan GP; Thompson J Clin J Sport Med; 2007 Jan; 17(1):43-8. PubMed ID: 17304005 [TBL] [Abstract][Full Text] [Related]
12. Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot study. van Grootheest AC; Groote JK; de Jong-van den Berg LT Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):475-81. PubMed ID: 14513661 [TBL] [Abstract][Full Text] [Related]
13. Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting. Christensen ST; Søndergaard B; Honoré PH; Bjerrum OJ Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):399-404. PubMed ID: 21442686 [TBL] [Abstract][Full Text] [Related]
15. "Trial" prescriptions to reduce drug wastage: results from Canadian programs and a community demonstration project. Paterson JM; Anderson GM Am J Manag Care; 2002 Feb; 8(2):151-8. PubMed ID: 11853203 [TBL] [Abstract][Full Text] [Related]
16. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions. Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362 [TBL] [Abstract][Full Text] [Related]
17. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics. Sturkenboom M; Nicolosi A; Cantarutti L; Mannino S; Picelli G; Scamarcia A; Giaquinto C; Pediatrics; 2005 Jul; 116(1):e26-33. PubMed ID: 15930187 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs. May FW; Rowett DS; Gilbert AL; McNeece JI; Hurley E Med J Aust; 1999 May; 170(10):471-4. PubMed ID: 10376022 [TBL] [Abstract][Full Text] [Related]
19. GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin. Pillai L; Burnett BP; Levy RM; Curr Med Res Opin; 2010 May; 26(5):1055-63. PubMed ID: 20225990 [TBL] [Abstract][Full Text] [Related]
20. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study. Ball D; Tisócki T Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]